Clinical Trials on High-Risk Non-Muscle-Invasive Bladder Cancer
Total 830 results
-
University of ZurichKessler Group; Rätsch Group; Slack Group; Boyman Group; Sunagawa Group; Zamboni Group; Loessner Group and other collaboratorsRecruitingChronic Pelvic Pain | Non-muscle-invasive Bladder Cancer | Asymptomatic Bacteriuria in Subjects Not Requiring Assisted Bladder Emptying | Asymptomatic Bacteriuria in Subjects Relying on Some Type of Catheter | Recurrent Non-catheter Associated UTIs | Acute Catheter-associated UTI (CAUTI) | Recurrent... and other conditionsSwitzerland
-
Fujian Medical University Union HospitalBeiGene; RemeGen Co., Ltd.Not yet recruiting
-
Lahore General HospitalCompletedUrinary Bladder Neoplasms | Non-muscle Invasive Bladder CancerPakistan
-
Xijing HospitalActive, not recruitingNon-muscle Invasive Bladder CancerChina
-
Aarhus University HospitalActive, not recruitingNon-muscle Invasive Bladder CancerDenmark
-
UroGen Pharma Ltd.TerminatedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel, Russian Federation, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Ukraine
-
Relmada Therapeutics, Inc.WithdrawnUrothelial Carcinoma Bladder | Urologic Cancer | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)
-
National Cancer Institute (NCI)RecruitingStage I Bladder Cancer AJCC v8 | Non-Muscle Invasive Bladder Urothelial Carcinoma | Recurrent Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States, Canada
-
Janssen Research & Development, LLCRecruitingNon-Muscle Invasive Bladder NeoplasmsUnited States, France, Israel, Germany, Belgium, China, Spain, Italy, United Kingdom, Netherlands, Japan, Argentina, Brazil, Greece, South Korea
-
Institut Claudius RegaudCepheidUnknownNon Muscle Invasive Bladder Cancer | Treatment by BCGFrance
-
Shanghai University of Traditional Chinese MedicineNot yet recruiting
-
Changhai HospitalRecruiting
-
Johns Hopkins UniversityRecruitingBladder Cancer | Cystectomy | Muscle Invasive Bladder Cancer Urothelial Carcinoma | Muscle Invasive Bladder Cancer (MIBC)United States
-
Ohio State University Comprehensive Cancer CenterRecruitingNon-Muscle Invasive Bladder CarcinomaUnited States
-
First Affiliated Hospital of Wenzhou Medical UniversityNot yet recruitingUrinary Bladder Neoplasms | Carcinoma, Transitional Cell | Carcinoma in Situ of Bladder | Non-Muscle-Invasive Bladder CancerChina
-
National Cancer Institute (NCI)Active, not recruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Non-Muscle Invasive Bladder Urothelial Carcinoma | Bladder Flat Urothelial Carcinoma In SituUnited States, Puerto Rico, Guam
-
CepheidAxonal-Biostatem; Stève ConsultantsCompletedNon-muscle-invasive Bladder CancerUnited Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
-
BioCis Pharma LtdTurku University Hospital; FinnMedi Oy; Tampere University HospitalCompletedCis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder CancerNon-muscle Invasive Bladder CancerFinland
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Mansoura UniversityRecruitingNon-Muscle Invasive Bladder CancerEgypt
-
Institut Paoli-CalmettesNot yet recruitingNon-muscle-invasive Bladder Cancer
-
Theralase® Technologies Inc.University Health Network, Toronto; Pharma eMarketRecruitingNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCGUnited States, Canada
-
University of Kansas Medical CenterVikor ScientificWithdrawnUrinary Tract Infections | Bladder CancerUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruitingNon-muscle-invasive Bladder CancerChina
-
Jørgen Bjerggaard JensenUniversity of AarhusRecruitingNon-Muscle Invasive Bladder CancerDenmark
-
Paolo PuppoCompletedNon Muscle Invasive Bladder CancerItaly
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Spain, Lithuania, Georgia, Bulgaria, Estonia, Latvia, Poland, Serbia, Austria
-
Helwan UniversityAin Shams University; Maadi Military HospitalCompletedBladder Transitional Cell CarcinomaEgypt
-
Aadi Bioscience, Inc.National Cancer Institute (NCI)CompletedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
University of OxfordMerck Sharp & Dohme LLCTerminatedNon-muscle Invasive Bladder Cancer (NMIBC)United Kingdom
-
Janssen Research & Development, LLCCompletedUrinary Bladder NeoplasmsUnited States, Japan, China, France, Belgium, Taiwan, Italy, Poland, United Kingdom, Spain, Australia, Czechia, Germany, Brazil, Argentina, India, South Korea
-
UroGen Pharma Ltd.Active, not recruitingBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Latvia, Georgia, Spain, Bulgaria, Estonia, Romania
-
University of California, DavisNational Cancer Institute (NCI)RecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Recurrent Non-Muscle Invasive Bladder CarcinomaUnited States
-
University of WashingtonPatient-Centered Outcomes Research InstituteActive, not recruitingBladder Cancer | Non-muscle Invasive Bladder Cancer | Cancer of the Bladder, RecurrentUnited States
-
National Taiwan University HospitalNational Taiwan UniversityRecruitingQuality of Life | Bladder CancerTaiwan
-
Astellas Pharma Global Development, Inc.Seagen, a wholly owned subsidiary of PfizerTerminatedCarcinoma in Situ | Urinary Bladder Neoplasms | Non-muscle Invasive Bladder Cancer | Carcinoma Transitional Cell | NMIBCUnited States, Spain, Canada, France, Germany, United Kingdom
-
Case Comprehensive Cancer CenterWithdrawnNon-muscle Invasive Bladder Cancer (NMIBC) | Bladder Tumor (TURBT)United States
-
Tongji HospitalNot yet recruitingMuscle-invasive Bladder Urothelial Carcinoma
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States
-
Relmada Therapeutics, Inc.Not yet recruitingUrothelial Carcinoma Bladder | Urologic Cancer | Urothelial Carcinoma Recurrent | Bladder (Urothelial, Transitional Cell) Cancer | Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)
-
Janssen Research & Development, LLCActive, not recruitingNon-Muscle Invasive Bladder NeoplasmsUnited States, Italy, Belgium, France, United Kingdom, Japan, Spain, China, Brazil, Germany, Poland, Romania, Argentina, South Korea
-
ImmVira Pharma Co. LtdRecruitingNonmuscle-invasive Bladder CancerUnited States
-
Wroclaw Medical UniversityCompletedRecurrence | Progression | Biomarkers | Bladder Cancer | Non-muscle Invasive Bladder Cancer | CystoscopyPoland
-
National and Kapodistrian University of AthensCompleted
-
Genomic Health®, Inc.CompletedNon-muscle Invasive Bladder CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
Fox Chase Cancer CenterCompletedMuscle Invasive Bladder Cancer | High Risk Urothelial Carcinoma of the Upper Urinary TractsUnited States
-
CG Oncology, Inc.WithdrawnBladder Cancer | High Grade | Non Muscle InvasiveUnited States
-
Tyra Biosciences, IncRecruitingFGFR Gene Amplification | FGFR3 Gene Mutation | FGFR3 Gene Alteration | FGFR Gene Alterations | FGFR3 Gene Fusions | Low-grade NMIBCUnited States, Spain, Italy, Australia
-
Mansoura UniversityUnknownNon-Muscle-invasive Bladder Cancer (NMIBC) | Bacillus Calmette-Guerin (BCG) Cystitis | Intra-vesical InstillationEgypt